Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Anti-Obesity Medicines--Athletes and GLP-1s: A Complex Relationship

Summary by La Presse
The return to the game of Serena Williams, facilitated by the use of anti-obesity drugs called "GLP-1 agonists", occurs while they are in the line of sight of the anti-doping authorities. Do these drugs, including Ozempic, give an unfair advantage to the athletes who take them?

1 Articles

La PresseLa Presse
Lean Left

Anti-Obesity Medicines--Athletes and GLP-1s: A Complex Relationship

The return to the game of Serena Williams, facilitated by the use of anti-obesity drugs called "GLP-1 agonists", occurs while they are in the line of sight of the anti-doping authorities. Do these drugs, including Ozempic, give an unfair advantage to the athletes who take them?

·Montreal, Canada
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Left
100% Left

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

La Presse broke the news in Montreal, Canada on Monday, July 20, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Serena Williams icon

Serena Williams

Montreal icon

Montreal

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal